Study of MAR002 in Healthy Men

Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects

NCT02145234 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of SHR -2001 in Healthy Subjects

NCT05942612 ·Status: COMPLETED ·Phase: PHASE1

Single-Ascending Dose Study of MK-2060 in Healthy Chinese Male Adult Participants (MK-2060-009)

NCT06843993 ·Status: COMPLETED ·Phase: PHASE1

PAC-14028 in Healthy Male Volunteers

NCT01264224 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Single Subcutaneous Dose Study of MLN1202

NCT02426021 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers

NCT06780254 ·Status: COMPLETED ·Phase: PHASE1

SAD and MAD Study of FTX-101 in Healthy Male Subjects

NCT06617546 ·Status: TERMINATED ·Phase: PHASE1

Study of Single Doses of SBT115301 in Healthy Participants

NCT05388981 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

NCT02338856 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects

NCT01858935 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers.

NCT07190716 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

NCT02140125 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects

NCT02790125 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects

NCT06022354 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants

NCT03002025 ·Status: COMPLETED ·Phase: PHASE1

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

NCT07219368 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

NCT02309008 ·Status: COMPLETED ·Phase: PHASE1

Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.

NCT04234594 ·Status: UNKNOWN ·Phase: PHASE1

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

NCT01737424 ·Status: COMPLETED ·Phase: PHASE1

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

NCT03173625 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

NCT05143905 ·Status: COMPLETED ·Phase: PHASE1

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects

NCT02293629 ·Status: COMPLETED ·Phase: PHASE1

A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants

NCT04628793 ·Status: COMPLETED ·Phase: PHASE1

A Study of Remternetug (LY3372993) in Healthy Chinese Participants

NCT07346495 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers

NCT00421226 ·Status: COMPLETED ·Phase: PHASE1